Great Point Partners as of March 31, 2021
Portfolio Holdings for Great Point Partners
Great Point Partners holds 28 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Macrogenics (MGNX) | 8.9 | $43M | 1.4M | 31.85 | |
| Rocket Pharmaceuticals (RCKT) | 7.0 | $34M | 760k | 44.37 | |
| Iovance Biotherapeutics (IOVA) | 6.1 | $29M | 930k | 31.66 | |
| Sage Therapeutics (SAGE) | 5.9 | $29M | 382k | 74.85 | |
| Intersect Ent | 5.8 | $28M | 1.3M | 20.88 | |
| Exelixis (EXEL) | 5.6 | $27M | 1.2M | 22.59 | |
| United Therapeutics Corporation (UTHR) | 5.4 | $26M | 156k | 167.27 | |
| Arena Pharmaceuticals Com New | 5.4 | $26M | 376k | 69.39 | |
| Insulet Corporation (PODD) | 4.8 | $23M | 90k | 260.92 | |
| Mirati Therapeutics | 4.8 | $23M | 135k | 171.30 | |
| Biogen Idec (BIIB) | 4.3 | $21M | 75k | 279.75 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 4.2 | $20M | 861k | 23.70 | |
| Constellation Pharmceticls I | 4.2 | $20M | 872k | 23.39 | |
| Kadmon Hldgs | 3.8 | $19M | 4.8M | 3.89 | |
| Ocular Therapeutix (OCUL) | 3.4 | $17M | 1.0M | 16.41 | |
| Travere Therapeutics (TVTX) | 3.1 | $15M | 594k | 24.97 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.9 | $14M | 650k | 21.37 | |
| Puma Biotechnology (PBYI) | 2.6 | $13M | 1.3M | 9.72 | |
| Nevro (NVRO) | 2.3 | $11M | 80k | 139.50 | |
| Inflarx Nv (IFRX) | 1.8 | $8.6M | 2.2M | 3.90 | |
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $8.0M | 311k | 25.80 | |
| Pulmonx Corp (LUNG) | 1.1 | $5.2M | 114k | 45.74 | |
| Redhill Biopharma Sponsored Ads | 1.1 | $5.2M | 705k | 7.32 | |
| Prometheus Biosciences | 0.9 | $4.6M | 250k | 18.26 | |
| Y Mabs Therapeutics (YMAB) | 0.9 | $4.5M | 150k | 30.24 | |
| Geron Corporation (GERN) | 0.9 | $4.1M | 2.6M | 1.58 | |
| Aeglea Biotherapeutics | 0.8 | $4.0M | 503k | 7.92 | |
| Tricida | 0.4 | $1.8M | 350k | 5.29 |
